NDRG2 and acute lymphoblastic leukemia: The effect of PRMT5 inhibitors has also been observed in NDRG2-expressing T-ALL cell lines, and PRMT5 is present in the cytoplasm and the nucleus, followed by the detection of H3R8me2s/H4R3me2s and the maintenance of physiological functions [10,13,14].